Beta Pharma, Inc.
Records under this name other than the patents Beta Pharma, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 13 patents it holds.
Showing 1 to 4 of 4 · Back to Beta Pharma, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,359,370 | Icotinib hydrochloride, synthesis, crystalline forms, pharmaceutical compositions, and uses thereof Lapsed on the fee record Ended Jun 7, 2024 · From the USPTO record | Lapsed on the fee record | Ended Jun 7, 2024 | From the USPTO record |
| US 7,078,409 | Fused quinazoline derivatives useful as tyrosine kinase inhibitors Term ended Term ended Oct 22, 2023 · From the USPTO record | Term ended | Term ended Oct 22, 2023 | From the USPTO record |
| US 8,822,482 | Icotinib hydrochloride, synthesis, crystalline forms, pharmaceutical compositions, and uses thereof Lapsed on the fee record Ended Sep 2, 2022 · From the USPTO record | Lapsed on the fee record | Ended Sep 2, 2022 | From the USPTO record |
| US 9,820,721 | Aspiration and biopsy needle apparatus and devices and applications thereof Lapsed on the fee record Ended Nov 21, 2021 · From the USPTO record | Lapsed on the fee record | Ended Nov 21, 2021 | From the USPTO record |